<DOC>
	<DOCNO>NCT02096302</DOCNO>
	<brief_summary>The purpose study determine whether infant formula supplement new probiotic CECT7210 , effective reduce incidence infection , specially gastrointestinal one .</brief_summary>
	<brief_title>The Effects Infant Formula Containing Probiotic CECT7210 Gastrointestinal Health</brief_title>
	<detailed_description>This multicenter , control , randomize , prospective , parallel , double-blinded study evaluate effect infant formula contain new probiotic , Bifidobacterium longum biovar infantis CECT7210 , incidence diarrhea healthy infant born term . Infants randomize take standard infant formula infant formula probiotic CECT7210 12 week .</detailed_description>
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<mesh_term>Digestive System Diseases</mesh_term>
	<criteria>Fullterm healthy newborn ( &gt; = 37 week ) Birth weight &gt; =2.500g &lt; =4.500g ) Normal growth curve ( 397 percentile ) 060 day age enrolment Maximum 30 day breastfeed Exclusively infant formula enrolment Breastfeeding infant formula pre/probiotics feed stop 15 day enrolment Parents caregiver agree exclude source prebiotics probiotic study Parents caregiver agree followon study 12 week Informed consent sign ( Parent/Legal representative ) Congenital illness malformation may affect infant feed /or normal growth Significant prenatal postnatal diseases Infant 's family history atopy Any pathology relate immune gastrointestinal system . Suspected known allergy cow 's milk protein Infants receive pre probiotic within less 15 day prior enrolment Infant 's family investigator 's assessment expect comply protocol</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>90 Days</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Probiotics</keyword>
	<keyword>Infant Formula</keyword>
	<keyword>Microbiota</keyword>
	<keyword>Bifidobacterium longum biovar infantis CECT7210</keyword>
	<keyword>Growth</keyword>
</DOC>